-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Calidi Biotherapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2022 to 2023.
- Calidi Biotherapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$5.77M, a 53.9% increase year-over-year.
- Calidi Biotherapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$23.2M, a 27.5% increase year-over-year.
- Calidi Biotherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$29.2M, a 14.9% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)